Piramal Pharma has committed to reduce its GHG emissions for Scope 1, 2, and 3 by 2030 MUMBAI, India, Sept. 16, 2024 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, has embarked on its sustainability journey as the Science…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.